Table 1. Clinical and biological... | American Society of Hematology

Table 1.

Clinical and biological features of P190^BCR/ABL patients with prolonged PCR-positive hematologic remission

Patient	Age (y)	WBC ×10⁹/L	Phenotype	Treatment	Maintenance	HCR duration (mo)	Outcome
1	29	54.2	Pre-B	CHT	CHT^*	114+	First HCR
2	22	13.1	Hybrid^†	CHT + ASCT	IFN-α	52	Relapsed, died

Patient	Age (y)	WBC ×10⁹/L	Phenotype	Treatment	Maintenance	HCR duration (mo)	Outcome
1	29	54.2	Pre-B	CHT	CHT^*	114+	First HCR
2	22	13.1	Hybrid^†	CHT + ASCT	IFN-α	52	Relapsed, died

WBC, white blood cell count; HCR, hematologic complete remission; CHT, chemotherapy; ASCT, autologous stem cell transplantation.

Patient received, in addition to chemotherapy maintenance, IFN-α for 1 year, due to HCV infection.

ALL blasts coexpressed myeloid antigens.